跳转至内容
Merck
所有图片(1)

文件

AB748

Sigma-Aldrich

抗IV型胶原抗体

Chemicon®, from rabbit

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

rabbit

品質等級

抗體表格

affinity isolated antibody

抗體產品種類

primary antibodies

無性繁殖

polyclonal

物種活性

human

製造商/商標名

Chemicon®

技術

ELISA: suitable
immunohistochemistry: suitable

適合性

not suitable for Western blot
not suitable for immunohistochemistry (Paraffin)

運輸包裝

dry ice

目標翻譯後修改

unmodified

基因資訊

human ... COL4A1(1282)

特異性

抗体与天然和热变性人IV型胶原蛋白反应。 与I、III、V型胶原的交叉反应性小于10%,与人II型胶原的交叉反应性小于1%。 抗血清通过固定化的人血浆蛋白和人I、III、V型胶原蛋白。人血浆蛋白不干扰与胶原蛋白的结合。

免疫原

纯化人IV型胎盘胶原蛋白

應用

人IV型胶原蛋白ELISA:1:3,000

IV型胶原在人体组织低温切片上的间接免疫荧光可视化:1:20-1:40,仅限新鲜冷冻或丙酮固定标本。

斑点和狭缝印迹:1:300。

不推荐用于蛋白质印迹,也不推荐用于石蜡包埋组织切片。

最佳工作稀释度必须由最终用户进行确定。
抗IV型胶原抗体可检测IV型胶原水平,已发布,经验证可用于ELISA、RIA、IH、IH(P)。
研究子类别
ECM 蛋白
研究类别
细胞结构

外觀

亲和纯化的交叉吸收抗血清抗体。 PBS溶液,含甘露醇、葡聚糖,不含防腐剂。
形式:纯化

儲存和穩定性

收到货后,在-20°C下以未稀释等分试样可保存长达12个月。应避免反复冻/融循环。

其他說明

浓度:请参考批次特异性浓缩物的检验报告。

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

Not finding the right product?  

Try our 产品选型工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Andrew R Findlay et al.
Neuromuscular disorders : NMD, 28(8), 675-679 (2018-06-24)
Mutations in MYH2 that encodes myosin heavy chain IIa cause both dominant and recessively inherited myopathies. Patients with dominantly inherited MYH2 missense mutations present with ophthalmoplegia and progressive proximal limb weakness. Muscle biopsy reveals rimmed vacuoles and inclusions, prompting this
Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo.
Damsky, CH; Fitzgerald, ML; Fisher, SJ
The Journal of Clinical Investigation null
Yonghui Ding et al.
Advanced healthcare materials, 6(11) (2017-03-25)
Pathological modification of the subendothelial extracellular matrix (ECM) has closely been associated with endothelial activation and subsequent cardiovascular disease progression. To understand regulatory mechanisms of these matrix modifications, the majority of previous efforts have focused on the modulation of either
Moa Lindgren et al.
Clinical & experimental metastasis, 38(2), 175-185 (2021-03-04)
No reliable, non-invasive biomarker of metastatic breast cancer (mBC) exists: circulating CA15-3 (cCA15-3) is the marker mostly used to monitor mBC. Circulating collagen IV (cCOLIV) has been evaluated in other metastatic cancers and has been found to be a promising
Fu Wei et al.
International journal of molecular sciences, 24(23) (2023-12-09)
The reproductive lifespan in humans is regulated by a delicate cyclical balance between follicular recruitment and atresia in the ovary. The majority of the small antral follicles present in the ovary are progressively lost through atresia without reaching dominance, but

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门